CL vs ELAB · P/E 34, rev $20.38B vs rev $1.7M
Colgate-Palmolive Company (CL) versus Elevai Labs, Inc. Common Stock (ELAB) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Elevai Labs, Inc. Common Stock (ELAB) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported ELAB revenue for 2023-12-31 was $1.7M. Net income was -$4.3M. Revenue was up 123.5% from 2022-12-31 to 2023-12-31. ELAB currently screens at market cap $6.5M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. ELAB currently screens at market cap $6.5M.
Not investment advice. Open the CL and ELAB stock pages for the full models.
Not investment advice.